Corvus Pharmaceuticals Inc. (CRVS) NASDAQ
$1.40 - (-)
Market Cap: $68.55M
As of 10/04/23 04:00 PM EDT. Market closed.
Corvus Pharmaceuticals Inc. (CRVS)
NASDAQ
$1.40
- (-)
Market Cap: $68.55M
As of 10/04/23 04:00 PM EDT. Market closed.
corvus pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development of novel, first-in-class agents that target the immune system to treat patients with cancer. with accomplished and talented scientists, and top-tier investors, we are well positioned in an exciting new era of ... read more
corvus pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development of novel, first-in-class agents that target the immune system to treat patients with cancer. with accomplished and talented scientists, and top-tier investors, we are well positioned in an exciting new era of immuno-oncology. read less
COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Richard Miller
Full Time Employees
36
CEO Compensation (Base)
$302,961
CEO Compensation (Total)
$1.36M
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Richard Miller
Full Time Employees
36
CEO Compensation (Base)
$302,961
CEO Compensation (Total)
$1.36M
Address
863 Mitten Rd Ste 102, California, Burlingame, 94010-1311.
PRICE CHART FOR CORVUS PHARMACEUTICALS INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$1.43
Previous Close
$1.40
Days Range
$1.38 - $1.44
52 week range
$0.61 - $4.19
Volume
46,846
Avg. Volume (30 days)
351,853
Market Cap
$68.55M
Dividend Yield
-
P/E
-
Shares Outstanding
48,965,862
Open
$1.43
Previous Close
$1.40
Days Range
$1.38 - $1.44
52 week range
$0.61 - $4.19
Volume
46,846
Avg. Volume (30 days)
351,853
Market Cap
$68.55M
Dividend Yield
-
P/E
-
Shares Outstanding
48,965,862
FINANCIAL STATEMENTS FOR CORVUS PHARMACEUTICALS INC
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR CORVUS PHARMACEUTICALS INC
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Grais Linda | Director | May 15, 2023 | Buy | $2.45 | 10,000 | 24,500 | 10,000 | May 16, 2023, 04:54 PM |
| Jones William Benton | See Remarks | Dec 20, 2022 | Buy | $0.79 | 20,000 | 15,800 | 133,773 | Dec 20, 2022, 06:22 PM |
| LEA LEIV | Chief Financial Officer | Dec 14, 2022 | Buy | $0.84 | 4,000 | 3,364 | 133,238 | Dec 15, 2022, 04:33 PM |
| LEA LEIV | Chief Financial Officer | Dec 13, 2022 | Buy | $0.74 | 30,000 | 22,275 | 129,238 | Dec 15, 2022, 04:33 PM |
| MILLER RICHARD A MD | President and CEO | Dec 14, 2022 | Buy | $0.78 | 10,000 | 7,812 | 1,490,119 | Dec 15, 2022, 04:32 PM |
| MILLER RICHARD A MD | President and CEO | Dec 13, 2022 | Buy | $0.74 | 50,000 | 37,015 | 1,480,119 | Dec 15, 2022, 04:32 PM |
| MILLER RICHARD A MD | President and CEO | Sep 28, 2022 | Buy | $0.76 | 25,000 | 19,070 | 1,394,405 | Sep 28, 2022, 05:45 PM |
| MILLER RICHARD A MD | President and CEO | Sep 20, 2022 | Buy | $0.81 | 20,000 | 16,253 | 1,369,405 | Sep 20, 2022, 06:58 PM |
| MILLER RICHARD A MD | President and CEO | Jun 27, 2022 | Buy | $1.00 | 5,000 | 4,985 | 1,349,405 | Jun 28, 2022, 07:15 PM |
| MILLER RICHARD A MD | President and CEO | Jun 24, 2022 | Buy | $1.03 | 5,000 | 5,150 | 1,344,405 | Jun 28, 2022, 07:15 PM |
| MILLER RICHARD A MD | President and CEO | Jun 06, 2022 | Buy | $1.01 | 890 | 899 | 1,339,405 | Jun 06, 2022, 06:43 PM |
| MILLER RICHARD A MD | President and CEO | Jun 02, 2022 | Buy | $0.98 | 5,000 | 4,898 | 1,338,515 | Jun 06, 2022, 06:43 PM |
| MILLER RICHARD A MD | President and CEO | Mar 31, 2022 | Buy | $1.64 | 15,000 | 24,534 | 1,333,515 | Apr 01, 2022, 04:18 PM |
| LEA LEIV | Chief Financial Officer | Mar 17, 2022 | Buy | $1.65 | 13,878 | 22,899 | 99,238 | Mar 17, 2022, 07:10 PM |
| LEA LEIV | Chief Financial Officer | Mar 16, 2022 | Buy | $1.54 | 35,160 | 54,146 | 85,360 | Mar 17, 2022, 07:10 PM |
| MILLER RICHARD A MD | President and CEO | Mar 17, 2022 | Buy | $1.59 | 5,000 | 7,950 | 1,318,515 | Mar 17, 2022, 07:09 PM |
| MILLER RICHARD A MD | President and CEO | Mar 15, 2022 | Buy | $1.47 | 25,000 | 36,650 | 1,313,515 | Mar 17, 2022, 07:09 PM |
| EcoR1 Capital, LLC | 10% Owner | Oct 01, 2021 | Sale | $4.96 | 2,000,000 | 9,928,800 | 81,077 | Oct 01, 2021, 07:39 PM |
| EcoR1 Capital, LLC | 10% Owner | Sep 30, 2021 | Sale | $5.04 | 3,000,000 | 15,131,101 | 2,081,077 | Oct 01, 2021, 07:39 PM |
| ORBIMED ADVISORS LLC | Director | Sep 20, 2021 | Sale | $6.09 | 1,109,644 | 6,757,732 | 6,943,654 | Sep 22, 2021, 05:27 PM |
| Thompson Peter A. | Director | Sep 20, 2021 | Sale | $6.09 | 1,109,644 | 6,757,732 | 6,943,654 | Sep 22, 2021, 05:24 PM |
| MILLER RICHARD A MD | President and CEO | Aug 20, 2021 | Buy | $1.93 | 10,000 | 19,254 | 1,288,515 | Aug 23, 2021, 09:01 PM |
| ORBIMED ADVISORS LLC | Director | Feb 17, 2021 | Buy | $3.50 | 1,285,714 | 4,499,999 | 8,053,298 | Feb 19, 2021, 04:52 PM |
| Thompson Peter A. | Director | Feb 17, 2021 | Buy | $3.50 | 1,285,714 | 4,499,999 | 8,053,298 | Feb 19, 2021, 04:47 PM |
| MILLER RICHARD A MD | President and CEO | Feb 17, 2021 | Buy | $3.50 | 100,000 | 350,000 | 1,278,515 | Feb 17, 2021, 04:44 PM |
| Novo Holdings A/S | 10% Owner | Jul 07, 2020 | Sale | $5.25 | 796,622 | 4,183,381 | 2,130,938 | Jul 09, 2020, 04:35 PM |
| Novo Holdings A/S | 10% Owner | Jul 08, 2020 | Sale | $5.37 | 741,440 | 3,985,166 | 1,389,498 | Jul 09, 2020, 04:35 PM |
| MILLER RICHARD A MD | President and CEO | Nov 13, 2019 | Buy | $3.00 | 14,736 | 44,240 | 1,178,515 | Nov 14, 2019, 04:14 PM |
| MILLER RICHARD A MD | President and CEO | Nov 12, 2019 | Buy | $2.90 | 272 | 789 | 1,163,779 | Nov 14, 2019, 04:14 PM |
| Thompson Peter A. | Director | Aug 06, 2019 | Buy | $3.51 | 142,656 | 500,723 | 6,767,584 | Aug 08, 2019, 05:00 PM |
| ORBIMED ADVISORS LLC | Director | Aug 06, 2019 | Buy | $3.51 | 142,656 | 500,723 | 6,767,584 | Aug 08, 2019, 04:59 PM |
| MILLER RICHARD A MD | President and CEO | Aug 06, 2019 | Buy | $3.58 | 5,000 | 17,875 | 1,161,007 | Aug 08, 2019, 04:07 PM |
| MILLER RICHARD A MD | President and CEO | Aug 07, 2019 | Buy | $3.54 | 2,500 | 8,850 | 1,163,507 | Aug 08, 2019, 04:07 PM |
| Novo Holdings A/S | 10% Owner | Jul 25, 2019 | Sale | $4.00 | 1,400,000 | 5,600,000 | 2,927,560 | Jul 25, 2019, 07:21 PM |
| Novo Holdings A/S | 10% Owner | Jul 24, 2019 | Sale | $5.01 | 53,240 | 266,711 | 4,327,560 | Jul 25, 2019, 07:21 PM |
| Novo Holdings A/S | 10% Owner | Jul 23, 2019 | Sale | $5.32 | 39,716 | 211,134 | 4,380,800 | Jul 25, 2019, 07:21 PM |
| Thompson Peter A. | Director | Jul 01, 2019 | Buy | $3.91 | 59,243 | 231,640 | 6,624,928 | Jul 01, 2019, 06:16 PM |
| Thompson Peter A. | Director | Jun 28, 2019 | Buy | $3.72 | 565,178 | 2,102,462 | 6,565,685 | Jul 01, 2019, 06:16 PM |
| Thompson Peter A. | Director | Jun 27, 2019 | Buy | $3.34 | 32,923 | 109,963 | 6,000,507 | Jul 01, 2019, 06:16 PM |
| ORBIMED ADVISORS LLC | Director | Jul 01, 2019 | Buy | $3.91 | 59,243 | 231,640 | 6,624,928 | Jul 01, 2019, 06:15 PM |
| ORBIMED ADVISORS LLC | Director | Jun 28, 2019 | Buy | $3.72 | 565,178 | 2,102,462 | 6,565,685 | Jul 01, 2019, 06:15 PM |
| ORBIMED ADVISORS LLC | Director | Jun 27, 2019 | Buy | $3.34 | 32,923 | 109,963 | 6,000,507 | Jul 01, 2019, 06:15 PM |
| MILLER RICHARD A MD | President and CEO | Jun 14, 2019 | Buy | $3.40 | 11,657 | 39,666 | 1,156,007 | Jun 17, 2019, 04:08 PM |
| MILLER RICHARD A MD | President and CEO | Jun 13, 2019 | Buy | $3.52 | 343 | 1,207 | 1,144,350 | Jun 17, 2019, 04:08 PM |
| MILLER RICHARD A MD | President and CEO | Jun 11, 2019 | Buy | $3.67 | 6,000 | 22,020 | 1,144,007 | Jun 11, 2019, 04:55 PM |
| MILLER RICHARD A MD | President and CEO | Jun 07, 2019 | Buy | $3.37 | 9,212 | 31,019 | 1,138,007 | Jun 11, 2019, 04:55 PM |
| LEA LEIV | Chief Financial Officer | Jun 07, 2019 | Buy | $3.38 | 10,000 | 33,800 | 50,200 | Jun 10, 2019, 04:12 PM |
| LEA LEIV | Chief Financial Officer | Jun 06, 2019 | Buy | $3.56 | 15,500 | 55,180 | 40,200 | Jun 10, 2019, 04:12 PM |
| MILLER RICHARD A MD | President and CEO | Dec 27, 2018 | Buy | $3.29 | 20,000 | 65,884 | 1,128,795 | Dec 31, 2018, 04:16 PM |
| LEA LEIV | Chief Financial Officer | Dec 21, 2018 | Buy | $4.15 | 24,700 | 102,409 | 24,700 | Dec 27, 2018, 04:08 PM |
| MILLER RICHARD A MD | President and CEO | Dec 20, 2018 | Buy | $4.39 | 10,000 | 43,950 | 1,108,795 | Dec 26, 2018, 04:05 PM |
| MILLER RICHARD A MD | President and CEO | Dec 06, 2018 | Buy | $5.99 | 5,000 | 29,934 | 1,118,795 | Dec 10, 2018, 04:05 PM |
| MILLER RICHARD A MD | President and CEO | Dec 04, 2018 | Buy | $5.95 | 1,502 | 8,937 | 1,113,795 | Dec 06, 2018, 04:06 PM |
| Thompson Peter A. | Director | Mar 12, 2018 | Buy | $8.50 | 588,235 | 4,999,998 | 5,967,584 | Mar 14, 2018, 02:05 PM |
| ORBIMED ADVISORS LLC | Director | Mar 12, 2018 | Buy | $8.50 | 588,235 | 4,999,998 | 5,967,584 | Mar 14, 2018, 01:58 PM |
| Novo Holdings A/S | 10% Owner | Mar 12, 2018 | Buy | $8.50 | 1,176,470 | 9,999,995 | 4,420,516 | Mar 13, 2018, 05:12 PM |
| Gould Terry P | Director | Mar 12, 2018 | Buy | $8.50 | 588,235 | 4,999,998 | 236,128 | Mar 13, 2018, 04:07 PM |
| ADAMS STREET PARTNERS LLC | 10% Owner | Mar 12, 2018 | Buy | $8.50 | 588,235 | 4,999,998 | 236,128 | Mar 13, 2018, 03:30 PM |
| MILLER RICHARD A MD | President and CEO | Mar 12, 2018 | Buy | $8.50 | 100,000 | 850,000 | 1,112,293 | Mar 12, 2018, 04:05 PM |
| MILLER RICHARD A MD | President and CEO | Nov 20, 2017 | Buy | $10.78 | 10,000 | 107,850 | 1,012,293 | Nov 22, 2017, 04:06 PM |
| Novo Holdings A/S | 10% Owner | Jun 23, 2017 | Buy | $10.95 | 20,000 | 219,000 | 3,244,046 | Jun 27, 2017, 04:52 PM |
| MILLER RICHARD A MD | President and CEO | Jun 13, 2017 | Buy | $9.95 | 5,000 | 49,725 | 1,002,293 | Jun 13, 2017, 04:06 PM |
| MILLER RICHARD A MD | President and CEO | Jun 12, 2017 | Buy | $9.82 | 11,216 | 110,185 | 997,293 | Jun 13, 2017, 04:06 PM |
| MILLER RICHARD A MD | President and CEO | Jun 09, 2017 | Buy | $9.92 | 8,784 | 87,174 | 986,077 | Jun 13, 2017, 04:06 PM |
| Thompson Peter A. | Director | Jun 24, 2016 | Buy | $12.99 | 900 | 11,691 | 5,379,349 | Jun 27, 2016, 06:51 PM |
| Thompson Peter A. | Director | Jun 23, 2016 | Buy | $12.92 | 100 | 1,292 | 5,378,449 | Jun 27, 2016, 06:51 PM |
| ORBIMED ADVISORS LLC | Director | Jun 24, 2016 | Buy | $12.99 | 900 | 11,691 | 5,379,349 | Jun 27, 2016, 06:47 PM |
| ORBIMED ADVISORS LLC | Director | Jun 23, 2016 | Buy | $12.92 | 100 | 1,292 | 5,378,449 | Jun 27, 2016, 06:47 PM |
| Thompson Peter A. | Director | Jun 21, 2016 | Buy | $12.87 | 26,083 | 335,688 | 5,378,349 | Jun 21, 2016, 07:00 PM |
| Thompson Peter A. | Director | Jun 17, 2016 | Buy | $12.48 | 12,300 | 153,504 | 5,352,266 | Jun 21, 2016, 07:00 PM |
| ORBIMED ADVISORS LLC | Director | Jun 21, 2016 | Buy | $12.87 | 26,083 | 335,688 | 5,378,349 | Jun 21, 2016, 06:55 PM |
| ORBIMED ADVISORS LLC | Director | Jun 17, 2016 | Buy | $12.48 | 12,300 | 153,504 | 5,352,266 | Jun 21, 2016, 06:55 PM |
| Thompson Peter A. | Director | Jun 16, 2016 | Buy | $12.04 | 5,000 | 60,200 | 5,339,966 | Jun 16, 2016, 06:05 PM |
| Thompson Peter A. | Director | Jun 15, 2016 | Buy | $11.94 | 5,000 | 59,700 | 5,334,966 | Jun 16, 2016, 06:05 PM |
| Thompson Peter A. | Director | Jun 14, 2016 | Buy | $12.71 | 10,000 | 127,100 | 5,329,966 | Jun 16, 2016, 06:05 PM |
| ORBIMED ADVISORS LLC | Director | Jun 14, 2016 | Buy | $12.71 | 10,000 | 127,100 | 5,329,966 | Jun 16, 2016, 05:59 PM |
| ORBIMED ADVISORS LLC | Director | Jun 16, 2016 | Buy | $12.04 | 5,000 | 60,200 | 5,339,966 | Jun 16, 2016, 05:59 PM |
| ORBIMED ADVISORS LLC | Director | Jun 15, 2016 | Buy | $11.94 | 5,000 | 59,700 | 5,334,966 | Jun 16, 2016, 05:59 PM |
| Thompson Peter A. | Director | Jun 10, 2016 | Buy | $12.98 | 20,000 | 259,600 | 5,319,966 | Jun 13, 2016, 05:23 PM |
| Thompson Peter A. | Director | Jun 09, 2016 | Buy | $12.95 | 30,000 | 388,500 | 5,299,966 | Jun 13, 2016, 05:23 PM |
| ORBIMED ADVISORS LLC | Director | Jun 10, 2016 | Buy | $12.98 | 20,000 | 259,600 | 5,319,966 | Jun 13, 2016, 05:18 PM |
| ORBIMED ADVISORS LLC | Director | Jun 09, 2016 | Buy | $12.95 | 30,000 | 388,500 | 5,299,966 | Jun 13, 2016, 05:18 PM |
| Thompson Peter A. | Director | May 20, 2016 | Buy | $13.09 | 4,716 | 61,732 | 5,269,966 | May 24, 2016, 04:48 PM |
| ORBIMED ADVISORS LLC | Director | May 20, 2016 | Buy | $13.09 | 4,716 | 61,732 | 5,269,966 | May 24, 2016, 04:37 PM |
| ORBIMED ADVISORS LLC | Director | May 19, 2016 | Buy | $12.13 | 2,600 | 31,525 | 5,265,250 | May 20, 2016, 05:21 PM |
| ORBIMED ADVISORS LLC | Director | May 18, 2016 | Buy | $11.55 | 4,200 | 48,510 | 5,262,650 | May 20, 2016, 05:21 PM |
| Thompson Peter A. | Director | May 18, 2016 | Buy | $11.55 | 4,200 | 48,510 | 5,262,650 | May 20, 2016, 04:27 PM |
| Thompson Peter A. | Director | May 19, 2016 | Buy | $12.13 | 2,600 | 31,525 | 5,265,250 | May 20, 2016, 04:27 PM |
| MILLER RICHARD A MD | President and CEO | May 13, 2016 | Buy | $9.94 | 300 | 2,981 | 1,077,293 | May 16, 2016, 06:38 PM |
| MILLER RICHARD A MD | President and CEO | May 12, 2016 | Buy | $10.00 | 30,000 | 300,000 | 1,076,993 | May 16, 2016, 06:38 PM |
| Novo A/S | 10% Owner | May 12, 2016 | Buy | $10.00 | 70,000 | 700,000 | 3,224,046 | May 16, 2016, 05:01 PM |
| Novo A/S | 10% Owner | Mar 29, 2016 | Buy | $15.00 | 666,666 | 9,999,990 | 3,154,046 | Mar 30, 2016, 01:07 PM |
| ORBIMED ADVISORS LLC | Director | Mar 29, 2016 | Buy | $15.00 | 550,000 | 8,250,000 | 5,258,450 | Mar 29, 2016, 12:21 PM |
| Thompson Peter A. | Director | Mar 29, 2016 | Buy | $15.00 | 550,000 | 8,250,000 | 5,258,450 | Mar 29, 2016, 12:00 PM |
| ADAMS STREET PARTNERS LLC | 10% Owner | Mar 29, 2016 | Buy | $15.00 | 200,000 | 3,000,000 | 736,033 | Mar 29, 2016, 11:54 AM |
| Gould Terry P | Director | Mar 29, 2016 | Buy | $15.00 | 200,000 | 3,000,000 | 736,033 | Mar 29, 2016, 11:39 AM |
Load More Insider Transactions
Buy
Sale
Option Exercise
Load More Insider Transactions
FUNDS WITH A POSITION IN CORVUS PHARMACEUTICALS INC
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| ORBIMED ADVISORS LLC | 6,943,654 | 0.29% | No change | Other |
| BLACKROCK INC. | 532,381 | 0.00003% | 7.94% | Other |
| RENAISSANCE TECHNOLOGIES LLC | 489,673 | 0.00162% | -3.23% | Other |
| GEODE CAPITAL MANAGEMENT, LLC | 342,079 | 0.00009% | 14.87% | Other |
CHANGE IN SHARES OUTSTANDING FOR CORVUS PHARMACEUTICALS INC
STOCK BUYBACKS FOR CORVUS PHARMACEUTICALS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 06/30/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
03/31/2023
2.02%
1Q
12/31/2022
2.03%
2Q
09/30/2022
2.03%
3Q
06/30/2022
2.03%
4Q
03/31/2022
2.03%
5Q
12/31/2021
1.92%
6Q
09/30/2021
8.08%
7Q
06/30/2021
12.43%
8Q
03/31/2021
37.61%
9Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR CORVUS PHARMACEUTICALS INC
LOADING...